Cleared Traditional

K191172 - Cepheid Xpert MRSA NxG Control Panel (FDA 510(k) Clearance)

Jun 2019
Decision
50d
Days
Class 2
Risk

K191172 is an FDA 510(k) clearance for the Cepheid Xpert MRSA NxG Control Panel. This device is classified as a Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays (Class II - Special Controls, product code PMN).

Submitted by Microbiologics, Inc. (St. Cloud, US). The FDA issued a Cleared decision on June 20, 2019, 50 days after receiving the submission on May 1, 2019.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3920. Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use..

Submission Details

510(k) Number K191172 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 01, 2019
Decision Date June 20, 2019
Days to Decision 50 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code PMN — Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3920
Definition Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use.